BRIEF published on 04/02/2026 at 07:05, 7 hours 3 minutes ago BioVersys nomme Anca Cighi à la tête des relations avec les investisseurs Biopharmaceutique Relations Avec Les Investisseurs BioVersys Anca Cighi Résistant Aux Médicaments
BRIEF published on 04/02/2026 at 07:05, 7 hours 3 minutes ago BioVersys Names Anca Cighi as Head of Investor Relations Investor Relations Biopharmaceutical BioVersys Anca Cighi Drug-resistant
PRESS RELEASE published on 04/02/2026 at 07:00, 7 hours 8 minutes ago BioVersys Appoints Anca Cighi as Head of Investor Relations and Communications BioVersys AG appoints Anca Cighi as Head of Investor Relations and Communications. Anca brings 15 years of experience to the role Investor Relations Communications BioVersys AG Antibacterial Products Anca Cighi
BRIEF published on 03/31/2026 at 07:05, 2 days 7 hours ago BioVersys et Hackensack Meridian Health collaborent à la recherche sur les mycobactéries non tuberculeuses (MNT). Collaboration BioVersys Ansamycin Recherche Sur Les Mycobactéries Non Tuberculeuses Méridien De Hackensack
BRIEF published on 03/31/2026 at 07:05, 2 days 7 hours ago BioVersys and Hackensack Meridian Health Collaborate on NTM Research Collaboration BioVersys Ansamycin NTM Research Hackensack Meridian
PRESS RELEASE published on 03/31/2026 at 07:00, 2 days 7 hours ago BioVersys strengthens Ansamycin platform and NTM research through collaboration and license agreement with Hackensack Meridian Health BioVersys strengthens Ansamycin platform and NTM research through collaboration and license agreement with Hackensack Meridian Health Collaboration BioVersys NTM Ansamycin Hackensack Meridian Health
BRIEF published on 03/18/2026 at 07:05, 15 days 7 hours ago BioVersys dévoile ses réalisations et ses performances financières pour 2025 Résultats Financiers Essais Cliniques BioVersys Médicaments Antibactériens Financement Des Introductions En Bourse
BRIEF published on 03/18/2026 at 07:05, 15 days 7 hours ago BioVersys Unveils 2025 Achievements and Financial Performance Financial Results Clinical Trials BioVersys Antibacterial Drugs IPO Funding
PRESS RELEASE published on 03/18/2026 at 07:00, 15 days 7 hours ago BioVersys Reports Corporate Highlights and Financial Results for the Full Year 2025 BioVersys AG reports corporate highlights and financial results for the full year 2025, including significant progress in clinical and regulatory advancements of antibacterial products for MDR bacteria Financial Results BioVersys AG Antibacterial Products Clinical Progress Regulatory Advancements
BRIEF published on 03/16/2026 at 07:05, 17 days 7 hours ago BioVersys Gets FDA Nod for BV100 Phase 3 Trial for Pneumonia FDA Approval Phase 3 Trial BV100 BioVersys CRAB Infections
Published on 04/02/2026 at 13:45, 23 minutes ago Amarc Confirms Boliden's Ongoing Participation at Duke Copper-Gold District and Provides District Update
Published on 04/02/2026 at 13:30, 38 minutes ago Revival Gold Consolidates Mercur Gold Project Paving The Way For Redevelopment
Published on 04/02/2026 at 13:15, 53 minutes ago F3 Announces Bought Deal Private Placement for Gross Proceeds of C$5 Million
Published on 04/02/2026 at 13:00, 1 hour 8 minutes ago Eagle Plains Partner Refined Energy Completes Drill Program at Dufferin West
Published on 04/02/2026 at 13:00, 1 hour 8 minutes ago Athena Gold Mobilizes For Maiden Drill Program At Laird Lake Project
Published on 04/02/2026 at 13:50, 18 minutes ago Hautalampi permitting process progressing – supplementary information request received
Published on 04/02/2026 at 13:43, 25 minutes ago Edison issues report on VinaCapital Vietnam Opportunity Fund (VOF)
Published on 04/02/2026 at 13:20, 48 minutes ago Phemex Publishes April 2026 Proof of Reserves, Reporting 131% Total Reserve Ratio
Published on 04/02/2026 at 13:05, 1 hour 3 minutes ago The Flamingo Estate Bathhouse by Kohler Debuts as a Nature‑Infused Wellness Sanctuary at Milan Design Week 2026
Published on 04/02/2026 at 13:05, 1 hour 3 minutes ago As Volatility Forces Brands to Rethink Business Resilience Strategies, UBQ Material's "Hero Product Challenge" Offers Price Stable Solution
Published on 04/02/2026 at 09:00, 5 hours 8 minutes ago STEF : Avis de mise à disposition des comptes annuels 2025
Published on 04/02/2026 at 08:30, 5 hours 38 minutes ago Edenred and EnBW partner to simplify electric fleet management in Germany
Published on 04/02/2026 at 08:30, 5 hours 38 minutes ago Edenred et EnBW s'associent pour simplifier la gestion des flottes électriques en Allemagne
Published on 04/02/2026 at 08:05, 6 hours 3 minutes ago Neoen announces the launch of France's largest battery
Published on 04/02/2026 at 08:05, 6 hours 3 minutes ago Neoen annonce le lancement de la plus grande batterie de France
